GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 90 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $296,000 | +10.0% | 24,201 | +6.1% | 0.00% | – |
| Q3 2016 | $269,000 | +49.4% | 22,820 | +10.2% | 0.00% | – |
| Q2 2016 | $180,000 | +69.8% | 20,714 | +3.1% | 0.00% | – |
| Q1 2016 | $106,000 | -28.4% | 20,099 | +5.4% | 0.00% | – |
| Q4 2015 | $148,000 | -34.5% | 19,066 | -33.7% | 0.00% | – |
| Q3 2015 | $226,000 | -11.4% | 28,754 | +2.0% | 0.00% | – |
| Q2 2015 | $255,000 | -28.2% | 28,190 | +3.0% | 0.00% | – |
| Q1 2015 | $355,000 | +12.0% | 27,361 | +17.5% | 0.00% | – |
| Q4 2014 | $317,000 | +40.3% | 23,278 | -7.7% | 0.00% | – |
| Q3 2014 | $226,000 | -34.7% | 25,227 | -1.3% | 0.00% | – |
| Q2 2014 | $346,000 | +31.1% | 25,559 | -3.9% | 0.00% | – |
| Q1 2014 | $264,000 | -18.3% | 26,593 | +9.4% | 0.00% | – |
| Q4 2013 | $323,000 | +18.3% | 24,304 | +8.2% | 0.00% | – |
| Q3 2013 | $273,000 | -95.8% | 22,456 | -96.4% | 0.00% | -100.0% |
| Q2 2013 | $6,462,000 | – | 624,510 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versor Investments LP | 2,664,831 | $63,689,000 | 3.80% |
| Chicago Capital Management, LLC | 318,113 | $7,603,000 | 3.54% |
| First Trust Capital Management L.P. | 564,758 | $13,498,000 | 2.64% |
| WATER ISLAND CAPITAL LLC | 1,693,162 | $40,467,000 | 2.47% |
| Sand Grove Capital Management LLP | 992,068 | $23,710,000 | 2.31% |
| EMC Capital Management | 121,023 | $2,892,000 | 2.06% |
| OMNI PARTNERS LLP | 1,540,671 | $36,822,000 | 1.82% |
| TIG Advisors, LLC | 1,774,849 | $42,419,000 | 1.60% |
| Cowen Prime Services LLC | 174,850 | $4,179,000 | 1.58% |
| G2 Investment Partners Management LLC | 396,400 | $9,474,000 | 1.50% |